Hepatitis C virus infection and clonal B-cell expansion

Clinical and Experimental Rheumatology

Volumn 14, Issue SUPPL. 14, 1996, Pages

  Sansonno, D ^a,b   Cornacchiulo, V ^a   Iacobelli, A R ^a   Gatti, P ^a   Distasi, M ^a   Dammacco, F ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b POLICLINICO   (Italy)

Author keywords

chronic liver disease; cryoglobulinemia; HCV; rheumatoid factor; WA cells

Indexed keywords

RHEUMATOID FACTOR;

ARTICLE; B LYMPHOCYTE; CRYOGLOBULINEMIA; HEPATITIS C; HUMAN; LYMPHOCYTE CLONE; PRIORITY JOURNAL;

B-LYMPHOCYTES; CLONE CELLS; CRYOGLOBULINEMIA; HEPACIVIRUS; HEPATITIS C; HUMANS; LYMPHOPROLIFERATIVE DISORDERS;

EID: 0029932433     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. HOUGHTON M, SELBY M. EINER A: Hepatitis C virus: structure, protein products and processing of the polyprotein precursor. In REESINK HW (Ed.): Hepatitis C Virus. Current Studies in Hematology and Blood Transfusion. Basel, Karger, 1994: 1-11.
2. SIMMONDS P: Variability of hepatitis C virus genome. In REESINK HW (Ed.): Hepatitis C Virus. Current Studies in Hematology and Blood Transfusion. Basel, Karger, 1994: 12-35.
3. ALTER MJ, MARGOLIS HS, KRAWCZYNSKI K: The natural history of community-acquired hepatitis C in the United States. N Engl JMed 1992; 327: 1899-1905.
4. HOFFMAN RM, DIEPOLDER HM, ZACHOVAL R et al.: Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 1995; 21: 632-8.
5. SANSONNO D, DAMMACCO F: Hepatitis C virus C100 antigen in liver tissue from patients with acute and chronic infection. Hepatology 1993; 18: 240-5.
6. NEGRO F, PACCHIONI D, SHIMIZU Y et al: Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology. Proc Natl Acad Sci USA 1992; 89: 2247-51.
7. MCFARLANE IG: Immunological abnormalities and hepatotropic viral infections. Clin Exp Immunol 1992; 87: 337-9.
8. LENZI M, JOHNSON PJ, MCFARLANE IG et al.: Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 1991; 338: 277-80.
9. MISHITO S, HOSHI Y, TAKEDA K et al.: Non-A, non-B hepatitis specific antibodies directed against a host-derived epitope: implication for an autoimmune process. Lancet 1990; 336: 1400-3.
10. FARGION S, PIPERNO A, CAPPELLINI MD et al.: Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 1992; 16: 1322-1326.
11. HADDAD J, DENY P, MUNZ-GOTHEIL C et al.: Lymphocytic sialoadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321-323.
12. SILVA M, LI X, CHEINQUER H et al.: HCV-associated idiopathic thrombocytopenic purpura (ITP). Gastroenterology 1992; 102: 889 (Abstract).
13. TRAN A, QUARANTA JF, BENZAKEN S et al.: High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 1993; 18: 253-7.
14. DAMMACCO F, SANSONNO D: Antibodies to hepatitis C virus in essential mixed cryoglobulinemia. Clin Exp Immunol 1992; 87: 352-6.
15. AGNELLO V, CHUNG RT, KAPLAN LM: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-5.
16. JOHNSON RJ, GRETCH DR, YAMABE H et al.: Membrano-proliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465-70.
17. FONG S, CHEN PP, GILBERTSON TA et al.: Expression of three cross-reactive idiotypes on rheumatoid factor autoantibodies from patients with autoimmune diseases and seropositive adults. J Immunol 1986; 137: 122-8.
18. SANSONNO D, IACOBELLI AR, CORNACCHIULO V et al.: Immunochemical and biomolecular studies of circulating immune complexes isolated from patients with acute and chronic hepatitis C virus infection. Eur J Clin Invest 1996; in press.
19. AGNELLO V, BARNES JL: Human rheumatoid factor crossidiotypes: I. WA and BLA are heat-labile conformational antigens requiring both heavy and light chains. J Exp Med 1986; 164: 1809-14.
20. KNIGHT GB, AGNELLO V, BONAGURA V et al: Human rheumatoid factor crossidiotypes. IV. Studies on WA XId-positive IgM without rheumatoid factor activity provide evidence that the WA XId is not unique to rheumatoid factor and is distinct from the 17.109 and G6 XId. J Exp Med 1993; 178: 1903-11.
21. FOX RL CHEN P, CARSON DA et al.: Expression of a cross-reactive idiotype on human rheumatoid factor in patients with Sjögren's syndrome. J Immunol 1986; 136: 477-83.
22. CARSON DA, CHEN PP, KIPPS TJ: New roles for rheumatoid factor. J Clin Invest 1991; 87: 379-83.
23. GOREVIC PD, FRANGIONE B: Mixed cryoglobulinemia cross-reactive idiotype: implications for the relationship of MC to rheumatic and lymphoproliferative diseases. Semin Hematol 1991; 28: 79-94.
24. SANSONNO D, CORNACCHIULO V, IACOBELLI AR et al.: Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology 1995; 21: 305-12.
25. LUNEL F: Hepatitis C virus and autoimmunity: Fortuitous association or reality? Gastroenterology 1994; 107: 1550-5.
26. CHOO QL, WEINER AJ, OVERBY LR et al.: Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull 1990; 86: 223-41.
27. SANSONNO D, DAMMACCO F: Antibodies to hepatitis C virus in non-A, non-B post transfusion and cryptogenetic chronic liver disease. Lancet 1989; ii: 798-9.
28. ROSS GD: Structure and function of membrane complement receptors. Fed Proc 1982; 41: 3089-93.
29. UNKELESS JC, WRIGHT SD: Structure and modulation of Fc and complement receptors. Contemp Top Immunobiol 1984; 14: 171-87.
30. PORTERFIELD JS: Antibody-dependent enhancement of viral infectivity. In MARAMOROSCH K, MURPHY FA, SHATKIN AJ (Eds.): Advances in Virus Research. VolXXXI. London, Academic Press Inc, 1986: 335-55.
31. PEIRIS JSM, PORTERFIELD JS: Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines. Nature 1979; 282: 509-11.
32. GABRIELLI A, MANZIN A, CANDELA M et al.: Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinemia. Clin Exp Immunol 1994; 97: 87-93.
33. FAN FS, TZENG CH, HSIAO KL et al.: Withdrawal of immunosuppressive therapy in allogenic bone marrow transplantation reactivates chronic viral hepatitis C. Bone Marrow Transplant 1991; 8: 417-20.
34. GAIDANO G, DALLA-FAVERA R et al.: Biologic and molecular chacterization of non-Hodgkin's lymphoma. Curr Opin Oncol 1993; 5: 776-84.
35. LUDWIG CH U, GENCIK M, SHIPMAN R: Multistep transformation in low-grade lymphoproliferative diseases. Ann Oncol 1993; 4: 825-30.
36. AGNELLO V: The aetiology of mixed cryoglobulinaemia associated with hepatitis C virus infection. Scand J Immunol 1995; 42: 1-6.
37. BONOMO L, CASATO M, AFELTRA A et al.: Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. Am J Med 1987; 83: 726-30.
38. CASATO M, LAGANA B, ANTONELLI G et al.: Long-term results of therapy with interferon-α for type II essential mixed cryoglobulinemia. Blood 1991; 78: 3142-7.
39. FERRI C, MARZO E; LONGOMBARDO G et al.: Interferon-α in mixed cryoglobulinemia patients: A randomized, cross-over-controlled trial. Blood 1993; 81: 1 132-6.
40. MISIANI R, BELLAVITA P, FENILI D et al: Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751-6.
41. DAMMACCO F, SANSONNO D, HAN JH et al: Natural interferon-α versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. Blood 1994; 84: 3336-43.
42. TERRAULT N, WRIGHT T: Interferon and hepatitis C. New Engl J Med 1995; 332: 1509-11.